(Q52881363)

9 May 2018

title

HLA and prognosis in multiple sclerosis. (English)

1 reference

9 May 2018

0 references

2

1 reference

9 May 2018

author name string

B Runmarker

series ordinal

1

1 reference

9 May 2018

J Wahlström

series ordinal

3

1 reference

9 May 2018

O Andersen

series ordinal

4

1 reference

9 May 2018

publication date

1 May 1994

1 reference

9 May 2018

published in

Journal of Neurology

1 reference

9 May 2018

volume

241

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

385-390

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/bf02033356

exact match

0 references

cites work

Takayasu's Disease: Association with HLA-B5

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02033356

On estimating the relation between blood group and disease

21 January 2018

1 reference

12 December 2020

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

1 reference

12 December 2020

Immunogenetic profile of multiple sclerosis in Mexicans

1 reference

12 December 2020

Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression

1 reference

12 December 2020

Multiple sclerosis: nature or nurture?

1 reference

12 December 2020

Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans

1 reference

12 December 2020

HLA class II genes: typing by DNA analysis

1 reference

12 December 2020

HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis

1 reference

12 December 2020

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

1 reference

12 December 2020

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

12 December 2020

On the evaluation of disability in multiple sclerosis

1 reference

12 December 2020

DNA-RFLP methods and interpretation scheme for HLA-DR and DQ typing

1 reference

12 December 2020

HLA-typing and lymphocyte population studies in patients with multiple sclerosis

1 reference

12 December 2020

HLA and heterogeneity of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis--more than one disease?

1 reference

12 December 2020

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

1 reference

12 December 2020

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

1 reference

12 December 2020

HLA-Dw1 and BfF as protective markers in multiple sclerosis.

1 reference

12 December 2020

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

12 December 2020

Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis

1 reference

12 December 2020

Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.

1 reference

12 December 2020

Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF

1 reference

12 December 2020

Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

1 reference

12 December 2020

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

1 reference

12 December 2020

Prognosis of multiple sclerosis. Results from an epidemiological area in Germany

1 reference

12 December 2020

1 reference

12 December 2020

DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression

1 reference

12 December 2020

A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10

1 reference

12 December 2020

A population-based study of multiple sclerosis in twins

1 reference

12 December 2020

HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology

1 reference

12 December 2020

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

12 December 2020

Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

HLA-antigens and the prognosis of multiple sclerosis

1 reference

12 December 2020

HLA antigens and progression of multiple sclerosis. Part II

1 reference

12 December 2020

HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course

1 reference

12 December 2020

Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or -DQ?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02033356

1 reference

9 May 2018

PubMed ID

7931434

1 reference

9 May 2018